文献速递心血管CT

多能CT衍生的心肌细胞外容积分数在慢性冠脉综合征患者非梗死节段的预后价值

Prognostic Value of Multienergy CT-derived Myocardial Extracellular Volume Fraction in Noninfarcted Segments of Individuals with Chronic Coronary Syndrome.
PubMed 文献 · Radiol Cardiothorac Imaging · 2026-01-01

本前瞻性研究纳入352例慢性冠脉综合征患者,在多能CT延迟碘增强后仅对无延迟碘增强的节段计算心肌细胞外容积分数(ECV),以中位数31%为界分组。中位随访41.7个月,76例发生主要不良心血管事件;高非梗死ECV独立预测MACE(HR 1.11),联合延迟碘增强可提高预测效能(C统计量0.80)。

要点

  • 仅对无延迟碘增强节段测量ECV,中位数31%为分组界值。
  • 高非梗死ECV独立预测MACE,校正延迟碘增强后HR 1.11(95%CI 1.04–1.18)。
  • 延迟碘增强联合ECV使MACE预测C统计量达0.80(95%CI 0.75–0.85)。

核心结论

  • 多能CT评估的非梗死ECV可独立预测慢性冠脉综合征患者的MACE,并提供增量预后价值。

研究设计与样本

  • 前瞻性研究,连续纳入2020年3月至2022年12月间接受冠状动脉CT血管成像后行多能CT延迟碘增强的慢性冠脉综合征患者352例(中位年龄68岁,IQR 60–74岁;男性233例)。
  • ECV仅从无延迟碘增强的节段衍生,以中位数-derived ECV截断值31%将参与者二分为高ECV组与低ECV组。
  • 随访记录主要不良心血管事件,包括心源性死亡、心力衰竭住院、心肌再梗死和恶性心律失常,中位随访41.7个月(IQR 33.9–51.3个月)。

关键影像表现/征象

  • 有延迟碘增强的参与者非梗死ECV高于无延迟碘增强者(中位数31.8% [IQR 29.4%–35.1%] vs 30.6% [IQR 28.5%–33.7%];P = .01)。

诊断标准与关键数值

  • 非梗死ECV以中位数31%为截断值分组,高ECV组较对照组MACE及心源性死亡风险更高(log-rank P < .05)。
  • 多变量Cox回归中,高非梗死ECV与MACE独立相关(HR 1.11 [95% CI: 1.04, 1.18];P < .001),校正变量包括延迟碘增强。
  • 将延迟碘增强与ECV同时纳入含临床、解剖和功能信息的基线模型,MACE预测效能提升(最终C统计量0.80 [95% CI: 0.75, 0.85];P < .001)。

临床应用与阅片要点

  • 在慢性冠脉综合征患者的多能CT延迟碘增强检查中,可对无延迟碘增强的心肌节段测量ECV用于风险分层。
  • 高非梗死ECV(≥31%)提示MACE和心源性死亡风险更高,报告时可结合延迟碘增强一并描述。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To evaluate the prognostic value of myocardial extracellular volume fraction (ECV) derived from multienergy CT with late iodine enhancement (LIE) in noninfarcted myocardial segments of individuals with chronic coronary syndrome (CCS). Materials and Methods This prospective study included consecutive participants with CCS who underwent LIE using multienergy CT following coronary CT angiography between March 2020 and December 2022. ECV was derived from only segments without LIE, and participants were dichotomized using a median-derived ECV cutoff value of 31%. Major adverse cardiovascular events (MACEs), including cardiac death, hospitalization for heart failure, myocardial reinfarction, and malignant arrhythmia, were recorded during follow-up. Kaplan-Meier and Cox regression analyses were performed to assess the association between noninfarcted ECV and MACEs. Results In total, 352 participants (median age, 68 years [IQR, 60-74 years]; 233 male) were included. During a median follow-up period of 41.7 months (IQR, 33.9-51.3 months), 76 participants experienced MACEs, including 17 cardiac deaths. Noninfarcted ECV was higher in participants with versus without LIE (median, 31.8% [IQR, 29.4%-35.1%] vs 30.6% [IQR, 28.5%-33.7%]; P = .01). Kaplan-Meier analysis showed that participants with high noninfarcted ECV had greater risk of MACEs and cardiac death (all log-rank P < .05). In multivariable Cox regression, high noninfarcted ECV remained independently associated with MACEs (hazard ratio, 1.11 [95% CI: 1.04, 1.18]; P < .001) after adjustment for covariates including LIE. Incorporating both LIE and ECV into a baseline model with clinical, anatomic, and functional information enhanced predictive performance for MACEs (final C-statistic, 0.80 [95% CI: 0.75, 0.85]; P < .001). Conclusion Noninfarcted ECV assessed using multienergy CT was independently predictive of MACEs and provided incremental prognostic value in individuals with CCS. Keywords: Applications-CT, Multienergy CT, Cardiac, Coronary Arteries © RSNA, 2026.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Xu Q, Liu Y, Guo Q, et al. Prognostic Value of Multienergy CT-derived Myocardial Extracellular Volume Fraction in Noninfarcted Segments of Individuals with Chronic Coronary Syndrome. Radiol Cardiothorac Imaging. 2026. PMID: 41569076. doi:10.1148/ryct.250053

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。